Citation Impact
Citing Papers
Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy
2008
Outcomes of Children With Intermediate-Risk Neuroblastoma After Treatment Stratified by MYCN Status and Tumor Cell Ploidy
2005
Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
2008
The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
2001
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors
2013
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006 Standout
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
2001
Adjuvant treatment of brain metastases
2001
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme
1998
The biologic basis for neuroblastoma heterogeneity and risk stratification
2005
Idiopathic pulmonary fibrosis
2017 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
MYC on the Path to Cancer
2012 Standout
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
2005
Liquid biopsy: monitoring cancer-genetics in the blood
2013
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Ganglioside GM2/GD2 Synthetase mRNA Is a Marker for Detection of Infrequent Neuroblastoma Cells in Bone Marrow
2001
Heating the patient: a promising approach?
2002 Standout
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Hyperthermia treatment planning
2000
Cancer Metastasis: Building a Framework
2006 Standout
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
2000
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Effector Mechanisms of Fenretinide-Induced Apoptosis in Neuroblastoma
2000
Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory Neuroblastoma
2003
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
2005
The cellular and molecular basis of hyperthermia
2002 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Notch signaling in neuroblastoma
2004
Upregulation of α-synuclein during localized radiation therapy signals the association of cancer-related fatigue with the activation of inflammatory and neuroprotective pathways
2012
Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: Results of the French STIC prospective study
2012
Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470
2000
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Cancer stem cells revisited
2017 Standout
Status of Clinical Hyperthermia
1999
Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases
2007 Standout
Magnetically mediated hyperthermia: current status and future directions
2002
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis
2001
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
2010
Detection of Minimal Residual Disease in Bone Marrow During or After Therapy as a Prognostic Marker for High-Risk Neuroblastoma
2001
c‐Kit is preferentially expressed in MYCN‐amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI‐571
2003
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathway
2011
The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation
2004
The golden age: gold nanoparticles for biomedicine
2011 Standout
Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
2009
Development of Fatigue in Cancer Survivors: A Prospective Follow-Up Study From Diagnosis Into the Year After Treatment
2012
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2
2013
Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy
2012
Recent Advances in Neuroblastoma
2010
Hyperthermia, Radiation and Chemotherapy: The Role of Heat in Multidisciplinary Cancer Care
2014
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study
2003
Retinoid therapy of high-risk neuroblastoma
2003
The promise of retinoids to fight against cancer
2001
Differentiating agents in pediatric malignancies: Retinoids in neuroblastoma
2000
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate
1997
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
2005
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat
2001
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls
2002
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Microenvironmental regulation of metastasis
2008 Standout
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
2012
Neuroblastoma
2007 Standout
Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases
2006 Standout
Disease Outcome May Be Predicted by Molecular Detection of Minimal Residual Disease in Bone Marrow in Advanced Neuroblastoma: A Pilot Study
2001
Protective and pathogenic functions of macrophage subsets
2011 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Mechanism and relevance of ploidy in neuroblastoma
2000
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer
2002
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
2005
A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer
2004
The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma
2006
Physical and biological predictors of changes in whole-lung function following thoracic irradiation
1997
Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival.
1996
Tumor response and toxicity with multiple infusions of high dose 131I‐MIBG for refractory neuroblastoma
2004
Cervical cancer
2019 Standout
Evaluation of semi‐quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
2006
Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings
2012
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
2007 Standout
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
2004 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
2007 Standout
Data maturity and follow-up in time-to-event analyses
2018
Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group
2005
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique
2005
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.
2001
Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study
2005
Induction of a VLA-2 (CD49b)-Expressing Effector T Cell Population by a Cell-Based Neuroblastoma Vaccine Expressing CD137L
2008
Targeting MYC-Regulated miRNAs to Combat Cancer
2010
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Disseminated Neuroblastoma in Children Older Than One Year at Diagnosis: Comparable Results With Three Consecutive High-Dose Protocols Adopted by the Italian Co-Operative Group for Neuroblastoma
2003
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
AIDS-Related Malignancies
2003
Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
2003
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Phase II Trial of the Anti-GD2Monoclonal Antibody 3F8 and Granulocyte-Macrophage Colony-Stimulating Factor for Neuroblastoma
2001
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
2009
Hematologic Toxicity of High-Dose Iodine-131–Metaiodobenzylguanidine Therapy for Advanced Neuroblastoma
2004
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
2000
Electrochemiluminescence (ECL)
2004 Standout
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
2002
Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer
2009
Quantitative Tumor Cell Content of Bone Marrow and Blood as a Predictor of Outcome in Stage IV Neuroblastoma: A Children’s Cancer Group Study
2000
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
Favorable Prognosis for Patients 12 to 18 Months of Age With Stage 4 Nonamplified MYCN Neuroblastoma: A Children's Cancer Group Study
2005
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Dinutuximab
2016
Cannabinoids for Medical Use
2015 Standout
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
2018 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Pilot Study of Iodine-131–Metaiodobenzylguanidine in Combination With Myeloablative Chemotherapy and Autologous Stem-Cell Support for the Treatment of Neuroblastoma
2002
Cytokine Genetic Variations and Fatigue Among Patients With Breast Cancer
2013
Extending Healthy Life Span—From Yeast to Humans
2010 StandoutScience
Achieving Integration in Mixed Methods Designs—Principles and Practices
2013 Standout
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
2001
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
2002
American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects
2007
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
CNS Metastases in Breast Cancer
2004
Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709)
2006
Works of Patrick S. Swift being referenced
Toxicities of total-body irradiation for pediatric bone marrow transplantation
1996
Trajectories of Fatigue in Men with Prostate Cancer Before, During, and After Radiation Therapy
2008
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.
1995
CT characteristics of patients with brain metastases treated in rtog study 79-16
1993
Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapy
2010
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
1999
Trajectories of Fatigue in Patients With Breast Cancer Before, During, and After Radiation Therapy
2010
Pulsed low dose rate brachytherapy for pelvic malignancies
1997
Preliminary Evidence of an Association Between a Functional Interleukin-6 Polymorphism and Fatigue and Sleep Disturbance in Oncology Patients and Their Family Caregivers
2010
Interstitial thermoradiotherapy with ferromagnetic implants for locally advanced and recurrent neoplasms
1993
ANAL NEOPLASIA
1996
Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: A prospectively controlled randomized study by the radiation therapy oncology group
1996
Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study
2003
Practices for Embedding an Interpretive Qualitative Approach Within a Randomized Clinical Trial
2013
Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate
1993
Preliminary Evidence of a Genetic Association Between Tumor Necrosis Factor Alpha and the Severity of Sleep Disturbance and Morning Fatigue
2009